Across TCGA pan-cancer cohorts, SNORA71A RNA is linked to patient survival in 25 of 34 cancer types, making it the most broadly survival-associated SNORA71A data layer compared with 1 for mutation status.
The strongest signal is observed in colon adenocarcinoma (COAD), where higher SNORA71A RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated SNORA71A expression acts as an unfavorable survival marker, although some lineages such as BRCA and GBM show a favorable association.
COAD, KIRC, and ACC are the cancer types where SNORA71A RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.